End-of-day quote
Taiwan S.E.
23:00:00 12/05/2024 BST
|
5-day change
|
1st Jan Change
|
13.15
TWD
|
+0.38%
|
|
+0.38%
|
-2.23%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,134
|
840.3
|
2,168
|
1,695
|
1,345
|
1,495
|
Enterprise Value (EV)
1 |
2,351
|
2,174
|
3,130
|
2,595
|
2,582
|
2,866
|
P/E ratio
|
-10.9
x
|
-8.48
x
|
51.3
x
|
9.53
x
|
-20.2
x
|
-9.88
x
|
Yield
|
-
|
-
|
-
|
6.56%
|
-
|
-
|
Capitalization / Revenue
|
0.28
x
|
0.26
x
|
0.82
x
|
0.47
x
|
0.48
x
|
0.61
x
|
EV / Revenue
|
0.57
x
|
0.66
x
|
1.19
x
|
0.73
x
|
0.93
x
|
1.17
x
|
EV / EBITDA
|
21.3
x
|
11.3
x
|
16.2
x
|
6.12
x
|
34.8
x
|
60
x
|
EV / FCF
|
36.9
x
|
34.6
x
|
7.71
x
|
-71.6
x
|
-12.3
x
|
-31.6
x
|
FCF Yield
|
2.71%
|
2.89%
|
13%
|
-1.4%
|
-8.14%
|
-3.16%
|
Price to Book
|
0.69
x
|
0.54
x
|
1.38
x
|
0.97
x
|
0.84
x
|
1.04
x
|
Nbr of stocks (in thousands)
|
111,157
|
111,157
|
111,157
|
111,157
|
111,157
|
111,157
|
Reference price
2 |
10.20
|
7.560
|
19.50
|
15.25
|
12.10
|
13.45
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/03/21
|
28/03/22
|
27/03/23
|
26/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,107
|
3,294
|
2,635
|
3,571
|
2,785
|
2,454
|
EBITDA
1 |
110.5
|
192.4
|
193.5
|
424.2
|
74.3
|
47.74
|
EBIT
1 |
-100.1
|
-5.771
|
14.75
|
237.8
|
-119.1
|
-154.6
|
Operating Margin
|
-2.44%
|
-0.18%
|
0.56%
|
6.66%
|
-4.28%
|
-6.3%
|
Earnings before Tax (EBT)
1 |
-113.6
|
-114.4
|
43.03
|
196.4
|
-64.21
|
-162.9
|
Net income
1 |
-104.4
|
-99.04
|
42.49
|
177.9
|
-66.74
|
-151.3
|
Net margin
|
-2.54%
|
-3.01%
|
1.61%
|
4.98%
|
-2.4%
|
-6.17%
|
EPS
2 |
-0.9400
|
-0.8910
|
0.3800
|
1.600
|
-0.6004
|
-1.362
|
Free Cash Flow
1 |
63.79
|
62.82
|
406
|
-36.24
|
-210.2
|
-90.58
|
FCF margin
|
1.55%
|
1.91%
|
15.41%
|
-1.01%
|
-7.55%
|
-3.69%
|
FCF Conversion (EBITDA)
|
57.73%
|
32.65%
|
209.81%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
955.48%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
1.000
|
-
|
-
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/03/21
|
28/03/22
|
27/03/23
|
26/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,218
|
1,333
|
963
|
900
|
1,237
|
1,371
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
11.02
x
|
6.929
x
|
4.976
x
|
2.122
x
|
16.65
x
|
28.73
x
|
Free Cash Flow
1 |
63.8
|
62.8
|
406
|
-36.2
|
-210
|
-90.6
|
ROE (net income / shareholders' equity)
|
-6.17%
|
-6.22%
|
2.59%
|
10.7%
|
-3.98%
|
-9.96%
|
ROA (Net income/ Total Assets)
|
-1.7%
|
-0.1%
|
0.27%
|
4.18%
|
-2.08%
|
-2.79%
|
Assets
1 |
6,147
|
97,193
|
15,727
|
4,251
|
3,215
|
5,426
|
Book Value Per Share
2 |
14.80
|
13.90
|
14.20
|
15.80
|
14.40
|
13.00
|
Cash Flow per Share
2 |
0.6900
|
0.4100
|
3.140
|
3.280
|
2.030
|
1.690
|
Capex
1 |
58.3
|
67.4
|
150
|
123
|
228
|
220
|
Capex / Sales
|
1.42%
|
2.04%
|
5.68%
|
3.44%
|
8.2%
|
8.98%
|
Announcement Date
|
29/03/19
|
30/03/20
|
29/03/21
|
28/03/22
|
27/03/23
|
26/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -2.23% | 44.86M | | +17.48% | 66.69B | | +1.61% | 49.2B | | +17.45% | 41.24B | | +20.17% | 25.89B | | +12.04% | 19.81B | | +2.48% | 17.11B | | -23.12% | 15.86B | | +2.57% | 15.35B | | -7.28% | 15.23B |
Other Specialty Chemicals
|